Levocetirizine Dihydrochloride API Market, Global Outlook and Forecast 2023-2030
Levocetirizine Dihydrochloride is the dihydrochloride salt form of the active levorotatory enantiomer of cetirizine, levocetirizine; a third generation, non-sedating, selective histamine H1 receptor antagonist, with antihistamine, anti-inflammatory and potential anti-angiogenic activities. Levocetirizine competes with endogenous histamine for binding at peripheral H1-receptor sites on the effector cell surface. This prevents the negative symptoms associated with histamine release and an allergic reaction. In addition, as histamine plays an important role in angiogenesis during an allergic inflammatory reaction, blocking the action of histamine may modulate the expression of proangiogenic factors and thus may prevent angiogenesis. As a third-generation histamine H1 receptor antagonist, levocetirizine has fewer side effects than most second-generation antihistamines.
This report aims to provide a comprehensive presentation of the global market for Levocetirizine Dihydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levocetirizine Dihydrochloride API. This report contains market size and forecasts of Levocetirizine Dihydrochloride API in global, including the following market information:
Global Levocetirizine Dihydrochloride API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Levocetirizine Dihydrochloride API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Levocetirizine Dihydrochloride API companies in 2022 (%)
The global Levocetirizine Dihydrochloride API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Levocetirizine Dihydrochloride API include Dr. Reddy?s Laboratories Ltd., Metrochem API Private Limited, Om Pharmaceutical Industries, Symed Labs Limited, Glenmark Pharmaceuticals, Granules India Limited, Chongqing Huapont Pharmaceutical, Glochem Industries and Cipla, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Levocetirizine Dihydrochloride API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Levocetirizine Dihydrochloride API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Levocetirizine Dihydrochloride API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Levocetirizine Dihydrochloride API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Levocetirizine Dihydrochloride API Market Segment Percentages, by Application, 2022 (%)
Levocetirizine Dihydrochloride Tablets
Levocetirizine Dihydrochloride Oral Solution
Others
Global Levocetirizine Dihydrochloride API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Levocetirizine Dihydrochloride API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Levocetirizine Dihydrochloride API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Levocetirizine Dihydrochloride API revenues share in global market, 2022 (%)
Key companies Levocetirizine Dihydrochloride API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Levocetirizine Dihydrochloride API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy?s Laboratories Ltd.
Metrochem API Private Limited
Om Pharmaceutical Industries
Symed Labs Limited
Glenmark Pharmaceuticals
Granules India Limited
Chongqing Huapont Pharmaceutical
Glochem Industries
Cipla
Nishchem International Pvt. Ltd
Maps Laboratories Private Limited
Supriya Lifescience Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Levocetirizine Dihydrochloride API, market overview.
Chapter 2: Global Levocetirizine Dihydrochloride API market size in revenue and volume.
Chapter 3: Detailed analysis of Levocetirizine Dihydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Levocetirizine Dihydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Levocetirizine Dihydrochloride API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
